氢化可的松
| 英文名 | Hydrocortisone | CAS号 | 50-23-7 |
| 试剂别名 |
11-B,17-A,21-TRIHYDROXY-4-PREGNEN-3,20-DIONE; 11BETA,17ALPHA,21-TRIHYDROXYPREGN-4-ENE-3,20-DIONE; 17ALPHA-HYDROXYCORTICOSTERONE; 17-HYDROXYCORTICOSTERONE; 4-PREGNEN-11BETA,11A,21-TRIOL-3,20-DIONE; 4-PREGNEN-11-BETA, 17,21-TRIOL-3,20-DIONE; 4-PREGNEN-11BETA,17ALPHA,21-TRIOL-3,20-DIONE; 4-PREGNEN-3,20-DIONE-11BETA,17ALPHA,21-TRIONE; 4-PREGNENE-11B,17A,21-TRIOL-3,20-DIONE; 4-PREGNENE-11BETA,17ALPHA,21-TRIOL-3,20-DIONE; (8S,9S,10R,11S,13S,14S,17R)-11,17-DIHYDROXY-17-(2-HYDROXY-ACETYL)-10,13-DIMETHYL-1,2,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-3-ONE; CORTISOL; DELTA4-PREGNEN-11BETA,17ALPHA,21-TRIOL-3,20-DIONE; HYDROCORTISONE BASE; HYDROCORTISONE, CYCLODEXTRIN-ENCAPSULATED
|
分子式 | C21H30O5 |
| 产品编号 | ad60344 | 分子量 | 362.46 |
| MDL号 | MFCD00011654 |
| 产品名称： | 氢化可的松 |
| 英文名称： | Hydrocortisone |
| 英文别名： | 11-B,17-A,21-TRIHYDROXY-4-PREGNEN-3,20-DIONE; 11BETA,17ALPHA,21-TRIHYDROXYPREGN-4-ENE-3,20-DIONE; 17ALPHA-HYDROXYCORTICOSTERONE; 17-HYDROXYCORTICOSTERONE; 4-PREGNEN-11BETA,11A,21-TRIOL-3,20-DIONE; 4-PREGNEN-11-BETA, 17,21-TRIOL-3,20-DIONE; 4-PREGNEN-11BETA,17ALPHA,21-TRIOL-3,20-DIONE; 4-PREGNEN-3,20-DIONE-11BETA,17ALPHA,21-TRIONE; 4-PREGNENE-11B,17A,21-TRIOL-3,20-DIONE; 4-PREGNENE-11BETA,17ALPHA,21-TRIOL-3,20-DIONE; (8S,9S,10R,11S,13S,14S,17R)-11,17-DIHYDROXY-17-(2-HYDROXY-ACETYL)-10,13-DIMETHYL-1,2,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-3-ONE; CORTISOL; DELTA4-PREGNEN-11BETA,17ALPHA,21-TRIOL-3,20-DIONE; HYDROCORTISONE BASE; HYDROCORTISONE, CYCLODEXTRIN-ENCAPSULATED |
| 中文别名： | 氢化可的松 ;皮质甾醇，氢化皮质素，氢化皮质酮，17-羟基皮质（甾）酮，可的索 |
| CAS No.： | 50-23-7 |
| 分子式： | C21H30O5 |
| 分子量： | 362.46 |
| 危险品级别： | |
| HS符号： | |
| 危害声明： |
